Atlas Trials

The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

Clinical trial NCT06208436 · UNKNOWN

Trial details

NCT number
NCT06208436
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreas CancerChemotherapy
Start date
2023-10-07
Primary completion
2024-02-15
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.